A phase III study comparing single-agent olaparib or the combination of cediranib and olaparib to standard platinum-based chemotherapy in recurrent platinum-sensitive ovarian cancer Meeting Abstract
| Authors: | Liu, J. F.; Brady, M. F.; Matulonis, U. A.; Miller, A.; Kohn, E. C.; Swisher, E. M.; Tew, W. P.; Cloven, N. G.; Muller, C.; Bender, D.; Moore, R. G.; Michelin, D. P.; Waggoner, S. E.; Geller, M. A.; Fujiwara, K.; D'Andre, S. D.; Carney, M.; Secord, A. A.; Moxley, K. M.; Bookman, M. A. |
| Abstract Title: | A phase III study comparing single-agent olaparib or the combination of cediranib and olaparib to standard platinum-based chemotherapy in recurrent platinum-sensitive ovarian cancer |
| Meeting Title: | 56th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 38 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2020 May 29-31 |
| Meeting Location: | Virtual Conference |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2020-05-20 |
| Language: | English |
| ACCESSION: | WOS:000560368302432 |
| PROVIDER: | wos |
| DOI: | 10.1200/JCO.2020.38.15_suppl.6003 |
| Notes: | Meeting Abstract: 6003 -- Source: Wos |
